Biohaven (also known as SpinCo, formerly known as Biohaven Research) is a biopharmaceutical company that develops therapies for diseases such as migraine, depression, bipolar, and schizophrenia. Its research programs focus on therapies with target indications, including epilepsy, mood disorders, OCD, SCA, SMA, and pain disorders. The key clinical programs include Kv7 Activator, Glutamate, Myostatin, and ARM.